S M Haffner

3.3k total citations · 1 hit paper
30 papers, 2.6k citations indexed

About

S M Haffner is a scholar working on Endocrinology, Diabetes and Metabolism, Public Health, Environmental and Occupational Health and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, S M Haffner has authored 30 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Public Health, Environmental and Occupational Health and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in S M Haffner's work include Diabetes, Cardiovascular Risks, and Lipoproteins (11 papers), Obesity, Physical Activity, Diet (6 papers) and Adipokines, Inflammation, and Metabolic Diseases (5 papers). S M Haffner is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (11 papers), Obesity, Physical Activity, Diet (6 papers) and Adipokines, Inflammation, and Metabolic Diseases (5 papers). S M Haffner collaborates with scholars based in United States, Paraguay and Mexico. S M Haffner's co-authors include Sharon P. Gaskill, M. P. Stern, Michael P. Stern, Heikki Miettinen, Helen P. Hazuda, Philip A Morales, Rodolfo Valdéz, Lynne E. Wagenknecht, Ralph B. D’Agostino and Marian Rewers and has published in prestigious journals such as JAMA, Gastroenterology and Endocrine Reviews.

In The Last Decade

S M Haffner

29 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes?

1990 810 citations S M Haffner JAMA profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
S M Haffner United States	19	1.7k	686	592	462	419	30	2.6k
Jan Cederholm Sweden	31	1.9k 1.1×	738 1.1×	450 0.8×	378 0.8×	393 0.9×	76	2.9k
Roberto Miccoli Italy	31	1.4k 0.8×	545 0.8×	828 1.4×	416 0.9×	332 0.8×	124	3.5k
M. Zenere Italy	13	1.3k 0.8×	642 0.9×	354 0.6×	855 1.9×	642 1.5×	22	2.7k
Philip A Morales United States	15	1.1k 0.7×	452 0.7×	337 0.6×	395 0.9×	313 0.7×	20	1.8k
Kwame Osei United States	31	1.6k 1.0×	395 0.6×	750 1.3×	632 1.4×	467 1.1×	108	2.9k
Johan Wadén Finland	32	1.7k 1.0×	780 1.1×	475 0.8×	369 0.8×	354 0.8×	50	3.2k
Jose R. Pio United States	12	1.1k 0.6×	906 1.3×	490 0.8×	539 1.2×	293 0.7×	15	2.3k
Michael Stern United States	7	1.3k 0.8×	473 0.7×	276 0.5×	563 1.2×	453 1.1×	12	2.1k
James W. Chu United States	14	1.1k 0.6×	427 0.6×	343 0.6×	525 1.1×	369 0.9×	27	2.0k
Olga Scherbakova United Kingdom	4	997 0.6×	522 0.8×	528 0.9×	705 1.5×	249 0.6×	4	2.2k

Countries citing papers authored by S M Haffner

Since Specialization

Citations

This map shows the geographic impact of S M Haffner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S M Haffner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S M Haffner more than expected).

Fields of papers citing papers by S M Haffner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S M Haffner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S M Haffner. The network helps show where S M Haffner may publish in the future.

Co-authorship network of co-authors of S M Haffner

This figure shows the co-authorship network connecting the top 25 collaborators of S M Haffner. A scholar is included among the top collaborators of S M Haffner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S M Haffner. S M Haffner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Martin, Nicholas G., et al.. (2012). Associations between surrogate measures of insulin resistance and waist circumference, cardiovascular risk and the metabolic syndrome across Hispanic and non‐Hispanic white populations. Diabetic Medicine. 29(11). 1390–1394. 11 indexed citations

Haffner, S M, Steven E. Kahn, B. Zinman, et al.. (2007). Greater reductions in C-reactive protein with rosiglitazone than with glyburide or metformin despite greater weight gain. Diabetologia. 50. 2 indexed citations

Haffner, S M. (1999). Reduced Coronary Events in Simvastatin-Treated Patients With Coronary Heart Disease and Diabetes or Impaired Fasting Glucose Levels. Archives of Internal Medicine. 159(22). 2661–2661. 328 indexed citations

Vauhkonen, Ilkka, et al.. (1998). Insulin resistant phenotype is associated with high serum leptin levels in offspring of patients with non-insulin-dependent diabetes mellitus. European Journal of Endocrinology. 139(6). 598–604. 11 indexed citations

Shoff, Suzanne, Polly A. Newcomb, Julie A. Mares‐Perlman, et al.. (1998). Usual consumption of plant foods containing phytoestrogens and sex hormone levels in postmenopausal women in Wisconsin. Nutrition and Cancer. 30(3). 207–212. 16 indexed citations

Haffner, S M. (1998). The Importance of Hyperglycemia in the Nonfasting State to the Development of Cardiovascular Disease. Endocrine Reviews. 19(5). 583–592. 31 indexed citations

Wagenknecht, Lynne E., Ralph B. D’Agostino, S M Haffner, et al.. (1998). Association of hormone replacement therapy and carotid wall thickness in women with and without diabetes.. Diabetes Care. 21(11). 1790–1796. 43 indexed citations

Gaskill, Sharon P., et al.. (1997). Waist Circumference as the Best Predictor of Noninsulin Dependent Diabetes Mellitus (NIDDM) Compared to Body Mass Index, Waist/hip Ratio and Other Anthropometric Measurements in Mexican Americans—A 7‐Year Prospective Study. Obesity Research. 5(1). 16–23. 386 indexed citations

Haffner, S M, Heikki Miettinen, & M. P. Stern. (1997). Relatively more atherogenic coronary heart disease risk factors in prediabetic women than in prediabetic men. Diabetologia. 40(6). 711–717. 88 indexed citations

10.

Haffner, S M, Heikki Miettinen, Sharon P. Gaskill, & M. P. Stern. (1996). Decreased insulin action and insulin secretion predict the development of impaired glucose tolerance. Diabetologia. 39(10). 1201–1207. 101 indexed citations

11.

Comuzzie, Anthony G., John Blangero, Michael C. Mahaney, et al.. (1996). Genetic and environmental correlations among hormone levels and measures of body fat accumulation and topography.. The Journal of Clinical Endocrinology & Metabolism. 81(2). 597–600. 42 indexed citations

12.

Mp, Stern, et al.. (1995). The insulin resistance syndrome in Mexico. Prevalence and clinical characteristics: a population based study.. PubMed. 26 Spec No. S9–15. 10 indexed citations

13.

González‐Villalpando, Clicerio, et al.. (1995). Carotid artery atherosclerosis in a Mexico City population with high carbohydrate intake.. PubMed. 26(4). 409–13. 1 indexed citations

14.

Siegel, David, et al.. (1994). Glucose and insulin levels during diuretic therapy in hypertensive men.. Hypertension. 23(6_pt_1). 688–694. 14 indexed citations

15.

Haffner, S M, Leena Mykkänen, Rodolfo Valdéz, & M. P. Stern. (1994). Evaluation of two insulin assays in insulin resistance syndrome (syndrome X).. Arteriosclerosis and Thrombosis A Journal of Vascular Biology. 14(9). 1430–1437. 15 indexed citations

16.

González‐Villalpando, Clicerio, et al.. (1993). [Prevalence of diabetes and glucose intolerance in a urban population at a low economic level].. PubMed. 44(3). 321–8. 18 indexed citations

17.

Ferrannini, Ele, S M Haffner, Martin Stern, et al.. (1991). High blood pressure and insulin resistance: influence of ethnic background. European Journal of Clinical Investigation. 21(3). 280–287. 47 indexed citations

18.

Haffner, S M. (1990). Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes?. JAMA. 263(21). 2893–2898. 810 indexed citations breakdown →

19.

Diehl, Andrew K., S M Haffner, J. AVA KNAPP, Helen P. Hazuda, & Michael P. Stern. (1989). Dietary intake and the prevalence of gallbladder disease in Mexican Americans. Gastroenterology. 97(6). 1527–1533. 33 indexed citations

20.

Stern, M. P., M Rosenthal, & S M Haffner. (1985). A new concept of impaired glucose tolerance. Relation to cardiovascular risk.. Arteriosclerosis An Official Journal of the American Heart Association Inc. 5(4). 311–314. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact